BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 12 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,000 | +64.3% | 2,500 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q2 2019 | $14,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q1 2019 | $14,000 | +16.7% | 2,500 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -14.3% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $14,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | +7.7% | 2,500 | 0.0% | 0.00% | – |
| Q4 2017 | $13,000 | -27.8% | 2,500 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 322,413 | $12,603,000 | 6.64% |
| MORGAN JESS S & CO INC | 74,464 | $2,911,000 | 2.90% |
| Mutual Advisors, LLC | 7,151 | $280,000 | 0.02% |
| BANK HAPOALIM BM | 6,510 | $254,000 | 0.01% |
| NEXT Financial Group, Inc | 1,350 | $53,000 | 0.01% |
| ARK Investment Management | 19,856 | $776,000 | 0.01% |
| HighTower Advisors, LLC | 17,900 | $701,000 | 0.00% |
| Edge Wealth Management LLC | 250 | $10,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 1,190 | $47,000 | 0.00% |
| ROYAL BANK OF CANADA | 3,607 | $141,000 | 0.00% |